The 2026 European Association of Urology (EAU) annual meeting featured a plenary prostate cancer session and a presentation ...
Although immunotherapy progress in prostate cancer has been slow, emerging strategies like bispecific T-cell engagers (BiTEs) show promise in overcoming historical resistance. In a recent discussion, ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果